Related references
Note: Only part of the references are listed.Development and validation of a histological index for UC
Mahmoud H. Mosli et al.
GUT (2017)
Development and validation of the Nancy histological index for UC
Aude Marchal-Bressenot et al.
GUT (2017)
Clinical remission in patients with moderate-to-severe Crohn's disease treated with filgotinib (the FITZROY study): results from a phase 2, double-blind, randomised, placebo-controlled trial
Severine Vermeire et al.
LANCET (2017)
Systematic review with meta-analysis: mucosal healing is associated with improved long-term outcomes in Crohn's disease
S. C. Shah et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2016)
Inherited determinants of Crohn's disease and ulcerative colitis phenotypes: a genetic association study
Isabelle Cleynen et al.
LANCET (2016)
Ustekinumab as Induction and Maintenance Therapy for Crohn's Disease
B. G. Feagan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target
L. Peyrin-Biroulet et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2015)
S100A12 concentrations and myeloperoxidase activity in the intestinal mucosa of healthy dogs
Mohsen Hanifeh et al.
BMC VETERINARY RESEARCH (2015)
Validation of Gene Expression Biomarker Analysis for Biopsy-based Clinical Trials in Crohn's Disease
Brigid S. Boland et al.
INFLAMMATORY BOWEL DISEASES (2015)
Early combined immunosuppression for the management of Crohn's disease (REACT): a cluster randomised controlled trial
Reena Khanna et al.
LANCET (2015)
Reproducibility of histological assessments of disease activity in UC
Mahmoud H. Mosli et al.
GUT (2015)
Identification of inflammatory mediators in patients with Crohn's disease unresponsive to anti-TNFα therapy
Raquel Franco Leal et al.
GUT (2015)
Assessment of Histologic Disease Activity in Crohn's Disease: A Systematic Review
Amirkaveh Mojtahed et al.
INFLAMMATORY BOWEL DISEASES (2014)
Systematic review: Histological remission in inflammatory bowel disease. Is 'complete' remission the new treatment paradigm? An IOIBD initiative
R. V. Bryant et al.
JOURNAL OF CROHNS & COLITIS (2014)
Mucosal Healing in Crohn's Disease: A Systematic Review
Peter De Cruz et al.
INFLAMMATORY BOWEL DISEASES (2013)
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
William J. Sandborn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Normalization of mucosal cytokine gene expression levels predicts long-term remission after discontinuation of anti-TNF therapy in Crohn's disease
Renathe Rismo et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2013)
Mucosal healing in inflammatory bowel diseases: a systematic review
Markus F. Neurath et al.
GUT (2012)
The effect of adalimumab for induction of endoscopic healing and normalization of mucosal cytokine gene expression in Crohn's disease
Renathe Rismo et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2012)
Mucosal Gene Expression of Cell Adhesion Molecules, Chemokines, and Chemokine Receptors in Patients With Inflammatory Bowel Disease Before and After Infliximab Treatment
Ingrid Arijs et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2011)
Mucosal Healing Predicts Sustained Clinical Remission in Patients With Early-Stage Crohn's Disease
Filip Baert et al.
GASTROENTEROLOGY (2010)
Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease.
Jean Frederic Colombel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Mucosal Healing Predicts Long-term Outcome of Maintenance Therapy with Infliximab in Crohn's Disease
Fabian Schnitzler et al.
INFLAMMATORY BOWEL DISEASES (2009)
Mucosal Gene Expression of Antimicrobial Peptides in Inflammatory Bowel Disease Before and After First Infliximab Treatment
Ingrid Arijs et al.
PLOS ONE (2009)
IL-23/IL-17 immunity as a hallmark of Crohn's disease
Veera Holtta et al.
INFLAMMATORY BOWEL DISEASES (2008)
Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease:: an open randomised trial
Geert D'Haens et al.
LANCET (2008)
PECAM-1 (CD 31) mediates transendothelial leukocyte migration in experimental colitis
Emile Rijcken et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2007)
The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications
J. Satsangi et al.
GUT (2006)
Myeloperoxidase: friend and foe
SJ Klebanoff
JOURNAL OF LEUKOCYTE BIOLOGY (2005)
Development and validation of a new, simplified endoscopic activity score for Crohn's disease: the SES-CD
M Daperno et al.
GASTROINTESTINAL ENDOSCOPY (2004)
Share Paper
